TY - JOUR
T1 - Mechanisms of dopaminergic and serotonergic neurotransmission in Tourette syndrome
T2 - Clues from an in vivo neurochemistry study with PET
AU - Wong, Dean F.
AU - Brašić, James R.
AU - Singer, Harvey S.
AU - Schretlen, David J.
AU - Kuwabara, Hiroto
AU - Zhou, Yun
AU - Nandi, Ayon
AU - Maris, Marika A.
AU - Alexander, Mohab
AU - Ye, Weiguo
AU - Rousset, Olivier
AU - Kumar, Anil
AU - Szabo, Zsolt
AU - Gjedde, Albert
AU - Grace, Anthony A.
N1 - Funding Information:
This work was supported by grant from PHS Grants RO1 MH078175, NS38927, K24 DA00412, RO1 AA12839. HSS currently has grant support from UCB Pharma, and has previously served as a consultant for Penwest and Shire. We thank the excellent editorial assistance of Melinda Roberson, PhD.
PY - 2008/5
Y1 - 2008/5
N2 - Tourette syndrome (TS) is a neuropsychiatric disorder with childhood onset characterized by motor and phonic tics. Obsessive-compulsive disorder (OCD) is often concomitant with TS. Dysfunctional tonic and phasic dopamine (DA) and serotonin (5-HT) metabolism may play a role in the pathophysiology of TS. We simultaneously measured the density, affinity, and brain distribution of dopamine D2 receptors (D2-R's), dopamine transporter binding potential (BP), and amphetamine-induced dopamine release (DA rel) in 14 adults with TS and 10 normal adult controls. We also measured the brain distribution and BP of serotonin 5-HT2A receptors (5-HT2AR), and serotonin transporter (SERT) BP, in 11 subjects with TS and 10 normal control subjects. As compared with controls, DArel was significantly increased in the ventral striatum among subjects with TS. Adults with TS+OCD exhibited a significant D2-R increase in left ventral striatum. SERT BP in midbrain and caudate/putamen was significantly increased in adults with TS (TS+OCD and TS-OCD). In three subjects with TS+OCD, in whom D2-R, 5-HT2AR, and SERT were measured within a 12-month period, there was a weakly significant elevation of DArel and 5-HT2A BP, when compared with TS-OCD subjects and normal controls. The current study confirms, with a larger sample size and higher resolution PET scanning, our earlier report that elevated DArel is a primary defect in TS. The finding of decreased SERT BP, and the possible elevation in 5-HT2AR in individuals with TS who had increased DA rel, suggest a condition of increased phasic DArel modulated by low 5-HT in concomitant OCD.
AB - Tourette syndrome (TS) is a neuropsychiatric disorder with childhood onset characterized by motor and phonic tics. Obsessive-compulsive disorder (OCD) is often concomitant with TS. Dysfunctional tonic and phasic dopamine (DA) and serotonin (5-HT) metabolism may play a role in the pathophysiology of TS. We simultaneously measured the density, affinity, and brain distribution of dopamine D2 receptors (D2-R's), dopamine transporter binding potential (BP), and amphetamine-induced dopamine release (DA rel) in 14 adults with TS and 10 normal adult controls. We also measured the brain distribution and BP of serotonin 5-HT2A receptors (5-HT2AR), and serotonin transporter (SERT) BP, in 11 subjects with TS and 10 normal control subjects. As compared with controls, DArel was significantly increased in the ventral striatum among subjects with TS. Adults with TS+OCD exhibited a significant D2-R increase in left ventral striatum. SERT BP in midbrain and caudate/putamen was significantly increased in adults with TS (TS+OCD and TS-OCD). In three subjects with TS+OCD, in whom D2-R, 5-HT2AR, and SERT were measured within a 12-month period, there was a weakly significant elevation of DArel and 5-HT2A BP, when compared with TS-OCD subjects and normal controls. The current study confirms, with a larger sample size and higher resolution PET scanning, our earlier report that elevated DArel is a primary defect in TS. The finding of decreased SERT BP, and the possible elevation in 5-HT2AR in individuals with TS who had increased DA rel, suggest a condition of increased phasic DArel modulated by low 5-HT in concomitant OCD.
KW - Brain imaging
KW - Dopamine
KW - Neurochemistry
KW - PET
KW - Serotonin
KW - Tourette's syndrome
UR - http://www.scopus.com/inward/record.url?scp=42049113400&partnerID=8YFLogxK
U2 - 10.1038/sj.npp.1301528
DO - 10.1038/sj.npp.1301528
M3 - Article
C2 - 17987065
AN - SCOPUS:42049113400
SN - 0893-133X
VL - 33
SP - 1239
EP - 1251
JO - Neuropsychopharmacology
JF - Neuropsychopharmacology
IS - 6
ER -